Clearside BioMedical Inc (CLSD):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Clearside BioMedical Inc (CLSD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7926
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Clearside BioMedical Inc (Clearside) is a clinical biopharmaceutical company that develops treatments for vision impairment associated with uveitic macular edema. The company’s pipeline products comprise Uveitis, macular edema associated with non- infectious uveitis; RVO – Retinal Vein Occlusion and DME – Diabetic Macular Edema and wet age related macular degeneration (wet AMD). Clearside’s proprietary suprachoroidal treatment approach offers unprecedented access to the back of the eye where sight threatening disease often occurs. The company also offers services such as business development, license agreements and contract manufacturing services. It markets its products across the US. Clearside is headquartered in Alpharetta, Georgia, the US.

Clearside BioMedical Inc (CLSD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Clearside BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Clearside BioMedical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Clearside BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Clearside BioMedical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Clearside BioMedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Clearside BioMedical Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Clearside Biomedical Acquires Patent Portfolio for Suprachoroidal Space Drug Delivery from iScience Interventional 10
Venture Financing 11
Clearside Biomedical Raises USD16 Million in Series B Venture Financing 11
Clearside Biomedical Raises US$8 Million In Venture Financing 13
Clearside Biomedical Raises Additional Funds In Series A Financing 15
Equity Offering 16
Clearside Biomedical Prices Public Offering of Shares for USD85 Million 16
Clearside BioMedical Inc – Key Competitors 18
Clearside BioMedical Inc – Key Employees 19
Clearside BioMedical Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Financial Announcements 21
Aug 08, 2018: Clearside Biomedical announces second quarter 2018 financial results and provides corporate update 21
May 09, 2018: Clearside Biomedical Announces First Quarter 2018 Financial Results 24
Mar 14, 2018: Clearside Biomedical Reports Fourth Quarter 2017 Financial Results 25
Nov 08, 2017: Clearside Biomedical Announces Third Quarter 2017 Financial Results and Provides Corporate Update 28
Aug 09, 2017: Clearside Biomedical Announces Second Quarter 2017 Financial Results and Provides Corporate Update 30
May 10, 2017: Clearside Biomedical Announces First Quarter 2017 Financial Results and Provides Corporate Update 32
Mar 14, 2017: Clearside Biomedical Announces Fourth Quarter And Full Year 2016 Financial Results 34
Corporate Communications 36
Sep 27, 2018: Clearside Biomedical appoints Jeffrey Edwards to board of directors 36
Sep 12, 2018: Clearside Biomedical appoints Viral Kansara as Vice President, discovery 37
Sep 11, 2018: Clearside Biomedical names Leslie Zacks as General Counsel and Chief Compliance Officer 38
Sep 06, 2018: Clearside Biomedical further strengthens commercial organization with appointment of lester rodríguez as vice president, quality 39
Jul 11, 2018: Clearside Biomedical Names Carol Hoang As Vice President, Medical Affairs 40
Feb 26, 2018: Clearside Biomedical Appoints William Humphries As Board Chairman And Brion Raymond As Chief Commercial Officer 41
Aug 08, 2017: Clearside Biomedical Announces Changes to its Board of Directors 43
Jan 04, 2017: Clearside Biomedical Appoints Richard Beckman, M.D., as Chief Medical Officer 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Clearside BioMedical Inc, Medical Equipment, Key Facts, 2017 2
Clearside BioMedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Clearside BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Clearside BioMedical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Clearside BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Clearside BioMedical Inc, Deals By Market, 2012 to YTD 2018 8
Clearside BioMedical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Clearside Biomedical Acquires Patent Portfolio for Suprachoroidal Space Drug Delivery from iScience Interventional 10
Clearside Biomedical Raises USD16 Million in Series B Venture Financing 11
Clearside Biomedical Raises US$8 Million In Venture Financing 13
Clearside Biomedical Raises Additional Funds In Series A Financing 15
Clearside Biomedical Prices Public Offering of Shares for USD85 Million 16
Clearside BioMedical Inc, Key Competitors 18
Clearside BioMedical Inc, Key Employees 19

List of Figures
Clearside BioMedical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Clearside BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Clearside BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Clearside BioMedical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Clearside BioMedical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Clearside BioMedical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Clearside BioMedical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Clearside BioMedical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Clearside BioMedical Inc (CLSD):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Regis Corporation (RGS):企業の財務・戦略的SWOT分析
    Regis Corporation (RGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Ishihara Sangyo Kaisha Ltd (4028):企業の財務・戦略的SWOT分析
    Ishihara Sangyo Kaisha Ltd (4028) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Bank of Taiwan:企業の戦略・SWOT・財務分析
    Bank of Taiwan - Strategy, SWOT and Corporate Finance Report Summary Bank of Taiwan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Global Petroleum Ltd (GBP):石油・ガス:M&Aディール及び事業提携情報
    Summary Global Petroleum Ltd (Global Petroleum) is an oil and gas company that offers oil and gas exploration and development services. The company operates through a portfolio of oil and gas projects in offshore Namibia and others. Its Namibian Project is into petroleum and gas exploration and Juan …
  • Macquarie Group Ltd:企業の戦略・SWOT・財務分析
    Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Bord na Mona Plc:企業の戦略的SWOT分析
    Bord na Mona Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Cooper-Standard Holdings Inc.:企業の戦略・SWOT・財務情報
    Cooper-Standard Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Cooper-Standard Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Hays plc:企業の戦略・SWOT・財務分析
    Hays plc - Strategy, SWOT and Corporate Finance Report Summary Hays plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Sime Darby Berhad:企業の戦略・SWOT・財務分析
    Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report Summary Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Pernod Ricard SA (RI):企業の財務・戦略的SWOT分析
    Pernod Ricard SA (RI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hey-Song Corporation:戦略・SWOT・企業財務分析
    Hey-Song Corporation - Strategy, SWOT and Corporate Finance Report Summary Hey-Song Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Beiersdorf AG:企業の戦略・SWOT・財務情報
    Beiersdorf AG - Strategy, SWOT and Corporate Finance Report Summary Beiersdorf AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • EnCana Corporation:企業の戦略・SWOT・財務情報
    EnCana Corporation - Strategy, SWOT and Corporate Finance Report Summary EnCana Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Close Brothers Asset Management:企業の戦略・SWOT・財務情報
    Close Brothers Asset Management - Strategy, SWOT and Corporate Finance Report Summary Close Brothers Asset Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Abivax SA (ABVX):企業の財務・戦略的SWOT分析
    Summary Abivax SA (Abivax) operates as a biotechnology company. It develops and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious and viral diseases. The company’s pipeline products include ABX464, ABX544 and ABX196. Its ABX464 is an oral small molecule to …
  • Acasti Pharma Inc (ACST):製薬・医療:M&Aディール及び事業提携情報
    Summary Acasti Pharma Inc (Acasti), a subsidiary of Neptune Technologies & Bioressources Inc, is a biopharmaceutical company that conducts research, development, and commercialization of krill oil-based forms of omega-3 fatty acids. The company develops phospholipid therapies for abnormalities in bl …
  • Oncolytics Biotech Inc (ONC)-医療機器分野:企業M&A・提携分析
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials indi …
  • Laboratorio Teuto Brasileiro SA-製薬・医療分野:企業M&A・提携分析
    Summary Laboratorio Teuto Brasileiro SA (Teuto), a subsidiary of Pfizer Inc is a drug company that develops, manufactures, and markets generic and over the counter products. The company’s products include aerodini aerosol salbutamol sulphate, afopic folic acid, albentel albendazole, acetato de dexam …
  • Summit Therapeutics Plc (SUMM)-製薬・医療分野:企業M&A・提携分析
    Summary Summit Therapeutics Plc (Summit), formerly Summit Corp Plc is a clinical-stage drug discovery and development company that offer therapies. The company conducts research and development on the treatment of rare diseases and infectious diseases including duchenne muscular dystrophy and the in …
  • Alps Electric Co., Ltd.:企業の戦略・SWOT・財務分析
    Alps Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Alps Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆